Adaptive Biotechnologies Corp
corporate_fare Company Profile
Adaptive Biotechnologies Corp (NASDAQ:ADPT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for ADPT at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Adaptive Biotechnologies Reports Strong 2025 Financials, Reduced Losses, and Positive Adjusted EBITDA
- Adaptive Biotechnologies Reports Strong Q4 & FY2025 Results, Achieves MRD Profitability, Guides for 2026 Growth
- Adaptive Biotechnologies Reports Strong Preliminary 2025 Results, Projects Profitability by End of 2026
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$276.98M
Net Income
-$59.5M
Diluted EPS
-$0.39
Op. Cash Flow
-$45.99M
Free Cash Flow
-$48.95M
Gross Profit
$205.62M
Operating Income
-$57.12M
Cash & Equivalents
$70.5M
Total Debt
$131.21M
Debt / Equity
0.60×
Net Margin
-21.5%
Shares Outstanding
153.78M sh
Source: 10-K · filed 2026-02-26 · accession 0001193125-26-076902
show_chartPrice Chart
Loading chart...
feed ADPT - Filings & News (Page 2)
ADPT
Feb 26, 2026, 4:31 PM EST
Price at Filing:
$15.77
Real-time Price:
$27.89
Change:
+$12.12 (+77%)
Market Cap:
$4.521B
ADPT
Feb 05, 2026, 4:15 PM EST
Price at Filing:
$17.50
Real-time Price:
$27.89
Change:
+$10.39 (+59%)
Market Cap:
$4.521B
ADPT
Jan 12, 2026, 8:15 AM EST
Price at Filing:
$18.00
Real-time Price:
$27.89
Change:
+$9.89 (+55%)
Market Cap:
$4.521B